• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[放疗联合甲硝唑治疗喉癌的形态学]

[Morphology of laryngeal cancer in radiotherapy combined with the use of metronidazole].

作者信息

Lushnikov E F, Andreev V G, Solov'eva L P

出版信息

Med Radiol (Mosk). 1985 Apr;30(4):25-32.

PMID:3990532
Abstract

The authors described clinicomorphological correlations in the evaluation of the efficacy of preoperative radiotherapy combined with metronidazole (MZ) in laryngeal cancer patients. A study was made of the tumors from 61 laryngeal cancer patients following radiation exposure at a summary dose of 20 and 32 Gy with and without MZ. Histological change of a tumor confirmed a radiosensitizing effect of MZ. However the MZ effect was not equally noticeable in tumor central and peripheral parts. Microscopic foci of the affected epithelium of the larynx and gland mucosa, muscular cells and vessels were revealed. MZ produces a stimulating effect on collagen production by fibroblasts.

摘要

作者描述了在评估术前放疗联合甲硝唑(MZ)对喉癌患者疗效时的临床形态学相关性。对61例喉癌患者的肿瘤进行了研究,这些患者接受了总剂量为20和32 Gy的辐射,部分患者使用了MZ,部分未使用。肿瘤的组织学变化证实了MZ的放射增敏作用。然而,MZ的作用在肿瘤中央和周边部分并不同样明显。发现了喉和腺体黏膜的受影响上皮、肌肉细胞和血管的微观病灶。MZ对成纤维细胞产生胶原的过程有刺激作用。

相似文献

1
[Morphology of laryngeal cancer in radiotherapy combined with the use of metronidazole].[放疗联合甲硝唑治疗喉癌的形态学]
Med Radiol (Mosk). 1985 Apr;30(4):25-32.
2
[The results of metronidazole use in radiation and combined treatment of patients with laryngeal cancer].[甲硝唑在喉癌患者放疗及综合治疗中的应用结果]
Med Radiol (Mosk). 1985 Apr;30(4):20-5.
3
[State of the liver after radiotherapy of cancer of the stomach and larynx with metronidazole radiosensitization].[甲硝唑增敏放疗胃癌和喉癌后肝脏的状态]
Med Radiol (Mosk). 1984 Dec;29(12):49-54.
4
[Combined (radiation and surgical) treatment of laryngeal cancer patients using metronidazole].[使用甲硝唑对喉癌患者进行(放疗和手术)联合治疗]
Med Radiol (Mosk). 1985 Aug;30(8):6-10.
5
[Direct and immediate results of the radiation and combined treatment of laryngeal cancer with local use of metronidazole].[喉癌放疗及联合局部应用甲硝唑治疗的直接即时效果]
Med Radiol (Mosk). 1986 Mar;31(3):20-4.
6
[Medullary hematopoiesis in laryngeal cancer during radiotherapy using metronidazole].[放疗期间使用甲硝唑治疗喉癌时的髓外造血]
Med Radiol (Mosk). 1984 Mar;29(3):13-20.
7
[Treatment of diffused laryngeal and pharyngeal cancer with preoperative radiotherapy in combination with radiation-modifying agents].[术前放疗联合放射修饰剂治疗弥漫性喉癌和咽癌]
Vestn Otorinolaringol. 1995 Jul-Aug(4):13-6.
8
Studies of metronidazole radiosensitizing effect in radiation treatment of patients with oral cavity cancer.甲硝唑在口腔癌患者放射治疗中放射增敏作用的研究。
Neoplasma. 1985;32(1):103-11.
9
[Effectiveness of repeated radiotherapy in patients with laryngeal cancer].[重复放疗对喉癌患者的疗效]
Med Radiol (Mosk). 1984 Jul;29(7):23-7.
10
[The hemostatic homeostasis of patients with malignant neoplasms of the larynx, stomach and uterine cervix during radiotherapy and radiosensitization with metronidazole].[喉、胃和宫颈癌恶性肿瘤患者在放疗及甲硝唑增敏放疗期间的止血稳态]
Radiobiol Radiother (Berl). 1990;31(6):523-9.